Description
Generic Version of Lapatinib Ditosylate Available in India?
Lapatinib Ditosylate is the generic name of the medication and is its international nonproprietary name. Lapatinib Ditosylate is marketed under the brand name Bretolap among others.
Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor (EGFR) pathways. It is used in combination therapy for HER2-positive breast cancer. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 (ErbB2).
In March 2007, the U.S. Food and Drug Administration (FDA) approved lapatinib in combination therapy for breast cancer patients already using capecitabine (Xeloda).
The drug lapatinib ditosylate is classified as S/NM (a synthetic compound showing competitive inhibition of the natural product) that is naturally derived or inspired substrate.
Will this product be accessible across all regions of India?
The product – Bretolap (Lapatinib Ditosylate) Tablets will be available across India on request. Lapatinib Ditosylate is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
FAQs
Is Bretolap (Lapatinib Ditosylate) Tablets launched in India?
Yes, Bretolap (Lapatinib Ditosylate) Tablets has been launched in India. It is available with Aark Pharmaceuticals.
What’s the cost price of Bretolap (Lapatinib Ditosylate) Tablets ?
Patients with a valid prescription, can send a request at Aark to get the best price of Bretolap (Lapatinib Ditosylate) Tablets in India. It can be delivered anywhere in India within 24-48 hours.
How to get Bretolap (Lapatinib Ditosylate) Tablets from Specialty Medicine Distributor in India?
Bretolap (Lapatinib Ditosylate) Tablets is available in India, to get or place an order from Specialty Medicine Distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
Note: Prior to consuming any medications, including “(Lapatinib Ditosylate) Tablets”, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects.
Availability
How to get access to FDA approved Bretolap (Lapatinib Ditosylate) Tablets in India?
Aark can help you to get access prescription medicines for personal use, FDA approved Bretolap (Lapatinib Ditosylate) Tablets in India. We have delivered Anti-cancer medicines – Bretolap (Lapatinib Ditosylate) Tablets to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
Disclaimer
Disclaimer: We hereby declare that Aark Pharmaceuticals exclusively exports biosimilars or generic medicines manufactured in India. We do not export products manufactured by multinational companies. Our commitment lies in offering cost-effective healthcare solutions through generic medications, ensuring accessibility and affordability for all our customers. For any inquiries or assistance regarding our product range, please feel free to contact us.
